Francesca Prignano1, Veronica Rogai2, Elisabetta Cavallucci3, Alessandro Bitossi2, Volker Hammen4, Fabrizio Cantini5. 1. Section of Dermatology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. 2. Eli Lilly Italia S.p.A., Florence, Sesto Fiorentino, Italy. 3. Eli Lilly Italia S.p.A., Florence, Sesto Fiorentino, Italy. cavallucci_elisabetta@lilly.com. 4. Lilly Deutschland GmbH, Bad Homburg, Germany. 5. Rheumatology Division, Hospital of Prato, Prato, Italy.
Abstract
PURPOSE OF REVIEW: Understanding prevalence of diseases within specific regions of a country is important for optimal allocation of healthcare resources/funds. We performed a systematic review to obtain a clearer picture of the epidemiology of psoriasis and psoriatic arthritis across and within specific regions of Italy. RECENT FINDINGS: Prevalence of psoriasis in specific regions showed more variability (0.8-4.5%) than that in the total population (1.8-3.1%). Prevalence of psoriatic arthritis in the general population was reported for only two regions, Chiavari (0.09%) and Marche (0.42%). All other studies reported prevalence of psoriatic arthritis in patients with psoriasis in single centres and Italy-wide (4.7-47.1%). Prevalence of psoriatic arthritis was highest in patients with nail and/or scalp psoriasis and/or intergluteal/perianal region involvement. Based on current available data, these conditions appear to affect a substantial number of people and will likely have an important impact on the Italian healthcare system.
PURPOSE OF REVIEW: Understanding prevalence of diseases within specific regions of a country is important for optimal allocation of healthcare resources/funds. We performed a systematic review to obtain a clearer picture of the epidemiology of psoriasis and psoriatic arthritis across and within specific regions of Italy. RECENT FINDINGS: Prevalence of psoriasis in specific regions showed more variability (0.8-4.5%) than that in the total population (1.8-3.1%). Prevalence of psoriatic arthritis in the general population was reported for only two regions, Chiavari (0.09%) and Marche (0.42%). All other studies reported prevalence of psoriatic arthritis in patients with psoriasis in single centres and Italy-wide (4.7-47.1%). Prevalence of psoriatic arthritis was highest in patients with nail and/or scalp psoriasis and/or intergluteal/perianal region involvement. Based on current available data, these conditions appear to affect a substantial number of people and will likely have an important impact on the Italian healthcare system.
Authors: C Bonifati; F Elia; F Francesconi; F Ceralli; S Izzi; F M Solivetti; C De Mutiis Journal: J Eur Acad Dermatol Venereol Date: 2011-06-04 Impact factor: 6.166
Authors: E Christophers; J N W N Barker; C E M Griffiths; E Daudén; G Milligan; C Molta; R Sato; R Boggs Journal: J Eur Acad Dermatol Venereol Date: 2009-10-23 Impact factor: 6.166
Authors: Stefano Piaserico; Paolo Gisondi; Paolo Amerio; Giuseppe Amoruso; Anna Campanati; Andrea Conti; Clara De Simone; Giulio Gualdi; Claudio Guarneri; Anna Mazzotta; Maria L Musumeci; Damiano Abeni Journal: Acta Derm Venereol Date: 2016-08-23 Impact factor: 4.437
Authors: Antonio Costanzo; Filomena Russo; Marco Galluzzo; Luca Stingeni; Roberta Scuderi; Leonardo Zichichi; Manuela Papini; Luisa Di Costanzo; Andrea Conti; Martina Burlando; Andrea Chiricozzi; Francesca Maria Gaiani; Cristina Mugheddu; Maria Letizia Musumeci; Paolo Gisondi; Stefano Piaserico; Paolo Dapavo; Marina Venturini; Gianluca Pagnanelli; Paolo Amerio; Concetta Potenza; Ketty Peris; Franca Cantoresi; Sara Trevisini; Francesco Loconsole; Annamaria Offidani; Santo Raffaele Mercuri; Viviana Lora; Francesca Prignano; Marta Bartezaghi; Giovanni Oliva; Elisabetta Aloisi; Roberto Orsenigo Journal: Acta Derm Venereol Date: 2021-10-21 Impact factor: 3.875
Authors: Federico Pirro; Giacomo Caldarola; Andrea Chiricozzi; Martina Burlando; Marco Mariani; Aurora Parodi; Ketty Peris; Clara De Simone Journal: Clin Drug Investig Date: 2021-09-18 Impact factor: 2.859